Free shipping on all orders over $ 500

FIIN-1

Cat. No. M28061

All AbMole products are for research use only, cannot be used for human consumption.

FIIN-1 Structure
Synonym:

FGFR irreversible inhibitor-1

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

FIIN-1 is a potent, irreversible, selective FGFR inhibitor. FIIN-1 binds to FGFR1/2/3/4 and Flt1/4 with Kds of 2.8/6.9/5.4/120 nM and 32/120 nM respectively. The biochemical IC50s of FIIN-1 are 9.2, 6.2, 11.9, and 189 nM against FGFR1/2/3/4, respectively.

Chemical Information
Molecular Weight 656.6
Formula C32H39Cl2N7O4
CAS Number 1256152-35-8
Form Solid
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Wenjun Zhou, et al. Chem Biol. A structure-guided approach to creating covalent FGFR inhibitors

Related FGFR Products
SNIPER(TACC3)-11 

SNIPER(TACC3)-11 is a potent FGFR3-TACC3 degrader.

LY-3076226

LY-3076226 is an antibody drug coupling (ADC) with a cleavable linker targeting FGFR2.

Aprutumab ixadotin

Aprutumab ixadotin is an antibody drug coupling (ADC) with a non-cleavable linker that targets FGFR2.

Gunagratinib

Gunagratinib is an orally active, potent, selective, and irreversible fibroblast growth factor receptor (pan-FGFR) inhibitor for use in cancer research.

SAR-442501

SAR-442501 is a novel anti-FGFR3 monoclonal antibody for studies related to achondroplasia (ACH).

  Catalog
Abmole Inhibitor Catalog




Keywords: FIIN-1, FGFR irreversible inhibitor-1 supplier, FGFR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.